期刊文献+

可切除肝门部胆管癌预后影响因素分析 被引量:12

Prognostic factors of survival in patients with resectable hilar cholangiocarcinoma
原文传递
导出
摘要 目的 研究对肝门部胆管癌预后影响最大的CA19-9的截点值,探索手术切除肝门部胆管癌患者的预后因素.方法 回顾性分析2003年4月至2009年1月于东方肝胆外科医院手术治疗的168例肝门部胆管癌患者资料.单因素分析其CA19-9水平对判断预后最有价值的截点,后行多因素分析,得出独立预后因素.结果 术前CA19-9水平对预后判断最有价值的截点值为150 kU/L(P<0.001).单因素分析显示年龄、肿瘤大小、分化程度、Bismuth-Corlette分型、门静脉侵犯、肝动脉侵犯、术前减黄、淋巴结转移及切缘均会影响肝门部胆管癌的预后.多因素分析证实只有淋巴结转移、切缘及CA19-9是影响肝门部胆管癌预后的独立危险因素.结论 CA19-9水平是影响肝门部胆管癌预后的独立因素,其对预后判断最有价值的截点是150 kU/L.结合术前CA19-9水平不仅有助于肝门部胆管癌患者的术前分期评估,而且有助于决定是否行腹腔探查并推断肝门部胆管癌的预后. Objective To investigate the appropriate cutoff point of CA19-9 in prognosis and to determine other potential prognostic factors which may affect survival of patients with hilar cholangiocarcinoma (HC) after radical surgery.Methods 168 patients who had undergone radical surgery for hilar cholangiocarcinoma with R0 and R1 resection were selected for the study.Categorized versions were used in univariate model to determine the appropriate cutoff point of CA19-9.CA19-9 and other clinicopathologic factors were analyzed for their influence on survival using multivariate methods.Results The strongest univariate predictor among the categorized preoperative CA19-9 measures was CA19-9 of less than 150 IU/L (P 〈0.001).On univariate analysis,age,differentiation,tumor size,Bismuth-Corlette classification,portal vein invasion,lymph node metastasis,hepatic artery invasion,liver invasion,preoperative biliary drainage,resection margin and preoperative CA19-9 levels were identified as significant prognostic factors.On multivariable analysis,lymph node metastasis,resection margin and preoperative CA19-9 levels were independent prognostic factors of survival.Conclusions A raised preoperative CA19-9 level was an independent prognostic factor of survival for hilar cholangiocarcinoma.The most discriminative cutoff point of CA19-9 for prognosis was at 150 kU/L.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第9期662-666,共5页 Chinese Journal of Hepatobiliary Surgery
基金 国家重大科技基金项目(2008ZX10002-025)
关键词 肝门部胆管癌 糖链抗原19-9 截点 淋巴结转移 切缘 影响因素 预后 Hilar cholangiocarcinoma Carbhydrate antigen 19-9, cutoff point Lymph node metastasis Resection margin Risk factors, prognosis
  • 相关文献

参考文献27

  • 1倪其泓,陈涛,王坚.肝门部胆管癌的分型分期与可切除性评估[J].中华肝胆外科杂志,2013,19(6):477-480. 被引量:16
  • 2张永杰.肝门部胆管癌外科诊疗中存在争议的若干问题[J].中华肝胆外科杂志,2011,17(2):88-91. 被引量:5
  • 3Nakeeb A,Pitt HA,Sohn TA,et al.Cholangiocarcinoma-a spec trum of intrahepatic,perihilar,and distal tumors[J].Ann Surg,1996,224(4):463-473.
  • 4Jonas S,Benckert C,Thelen A,et al.Radical surgery for hilar cholangiocarcinoma[J].Eur J Surg Oncol,2008,34 (3):263-271.
  • 5Konstadoulakis MM,Roayaie S,Gomatos IP,et al.Aggressive surgical resection for hilar cholangiocarcinoma:is it justified? Audit of a single center's experience[J].Am J Surg,2008,196(2):160-169.
  • 6Del Villano BC,Brennan S,Brock P,et al.Radioimmunometric assay for a monoclonal antibody-defined tumor marker CA19-9[J].Clin Chem,1983,29(6):549-552.
  • 7Ohtsuka MH,Kimura F,Shimizu H,et al.Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathologi cal factors influencing survival[J].Br J Surg,2002,89 (12):1525-1531.
  • 8Heimbach JK,Gores GJ,Haddock MG,et al.Predictors of dis ease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma[J].Transplantation,2006,82(12):1703-1707.
  • 9Kim H J,Yun SS,Jung KH,et al.Intrahepatic cholangiocarcinoma in Korea[J].J Hepatobiliary Pancreat Surg,1999,6 (2):142-148.
  • 10Miwa S,Miyagawa S,Soeda J,et al.Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcino ma[J].Cancer,2002,94(2):428-434.

二级参考文献38

  • 1张斌,顾磊,吴志勇.肝门胆管癌的可切除性评估[J].中华外科杂志,2007,45(11):783-785. 被引量:2
  • 2Bismuth H, Nakache R, Diamond T. Management strategies in resection tor hilar cholangiocarcinoma[J]. Ann Surg, 1992, 215:31.
  • 3Liang Y, Ye s, Shi X, et al. Experiences of microsurgical re- construction for variant hepatic artery in living donor liver transplantation[J]. Cell Bioch g> Biophysic, 2013, 65: 257-262.
  • 4Lillemoe KD. Surgery for hilar cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sury, 2000,7 : 115- 121.
  • 5Regimbeau JM, Fuks D, Le Treut YP, et al. Surgery for hi- larcholangiocarcinoma: a nmylti institutional upate on practice and outcome by the AFC HC study group[J]. J Gastrointest Surg, 2011,15 :480-488.
  • 6Miyazaki M, Kimura F, Shimizu H, et al. One hundred seven consecutive surgical resections for hilarcholangioeacinoma of Bismuth types 1I ,ll[ , N between 2001 and 2008[J]. J Hepato- biliary Pancreat Sei, 2010,17 = 470-475.
  • 7Tsao Ji, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and Japanese experience[J]. Ann Surg, 2000,232 : 166-174.
  • 8Madariaga JR, Iwatsuki S, Todo S, et aI. laver resection for hilar and peripheral cholangiocarcinomas: study of 62 cases [J]. Anno Surg, 1998,227:70-79.
  • 9Okuda k,Ohto M, Tsuchiya T. The role of ultrasound, percu- tanous trans hepatic cholangiography, computed tomographic scanning and magnetic resonance imaging in the preoperative assessment for bile duct cancer[J]. World J Surg, 1988,12: 18-26. M.
  • 10iyazaki M, Ito H, Nakagawa K, et al. Unilaleral epatic ar tery reconstruction is unnecessary in hiliary tract carcinoma in- volving lobar hepatic artery: implications of inter lobar hepatic artery and its preservation [J]. Hepatogastroenterology, 2000,47 : 1526-1530.

共引文献28

同被引文献115

  • 1Jun-Jie Xiong,Quentin M Nunes,Wei Huang,Samir Pathak,Ai-Lin Wei,Chun-Lu Tan,Xu-Bao Liu.Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy[J].World Journal of Gastroenterology,2013,19(46):8731-8739. 被引量:33
  • 2黄志强.肝门部胆管癌外科治疗的现状与展望[J].中国普外基础与临床杂志,2005,12(4):317-320. 被引量:28
  • 3张云利,胡建国,杨立涛,郭剑民,周立新.POSSUM评分对65岁以上老年人胰十二指肠切除术的意义[J].中国肿瘤临床,2006,33(18):1061-1063. 被引量:4
  • 4周宁新,黄志强,张文智,黄晓强,王敬,刘荣,纪文斌,肖梅,孟翔飞.402例肝门部胆管癌临床分型、手术方式与远期疗效的综合分析[J].中华外科杂志,2006,44(23):1599-1603. 被引量:95
  • 5Fukude S, Mukai S, Shimizu S, et al. Heterotopic gastric mu-cosa in the hilar bile duct mimicking hilar cholangiocarcinoma :Report of a case [J]. Surgery Today, 2013,43(1) :91-95.
  • 6王娟,公维宏,张宏涛.放射性M粒子植人治疗消化道恶性肿瘤的临床分析[C].天津:中国抗癌协会,2013.
  • 7Sasaki R,Takeda Y,Funato O,et al.Significance of ductal mar- gin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma[J].World J Surg,2007,31(9):1788-1796.
  • 8Nagahashi M,Shirai Y,Wakai T,et al.Depth of invasion deter- mines the postresectional prognosis for patients with Tl extrahepa- tic cholangiocarcinoma[J].Cancer,2010,116(2):400-405.
  • 9Nitta T,Mitsuhashi T,Hatanaka Y,et al.Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma:comprehensive immunohistochemical study using a tissue microarray[J].Br J Cancer,2014,111(7):1363-1372.
  • 10Oshiro Y,Sasaki R,Kobayashi A,et al.Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholan- giocarcinoma[J].Eur J Surg Oncol,2011,37(1);60-64.

引证文献12

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部